Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by subaru1on Jul 07, 2024 1:49pm

RE:Headset data.

It is positive but that shows very small revenue.
21
Discussion
Comment by QContinuum1on Jul 05, 2024 12:38pm

RE:Headset data.

Appears positive certainly.  What comes of the positivity, who knows.
36
Discussion
Post by alleyesonmeon Jul 05, 2024 11:43am

Headset data.

https://www.headset.io/brands/medipharm-labs
102
Discussion
Post by pidukson Jul 05, 2024 10:20am

Dave, you won't tell them that and make the

shareholders wait, so FU, the news is out.  Sue me you POS.  And think twice before you cross the border if they let you in. 
57
Post by pidukson Jul 05, 2024 10:18am

3rd drug approval completes the package for Apotex

2 Brazil, generic Epidiolex pending FDA.   Parrot Dave, a real POS. 
67
Comment by Starkickeron Jul 04, 2024 9:13pm

RE:Blatant lie in less than 6 months?

Ed, calm down. Athea needs to give you your meds.And you're not fooling anybody with your new handle and persona. It looks like this stock has sent you and Alleyesonme to the asylum. It is amazing ...more  
83
Discussion
Post by pidukson Jul 04, 2024 6:46pm

How stupid is stupid? Like a broken parrot talking

of 'mergers and acquisitions' instead of giving shareholder clarity of generic Epidiolex launch and the company bleeding red ink at the bottom line.   He is an IDIOT sales rep that ...more  
73
Post by pidukson Jul 04, 2024 6:43pm

Blatant lie in less than 6 months?

'launching generic Epidiolex in the U.S. this year' Dave, why didn't you bother submitting to Health Canada for generic Epidiolex also?  Where is your Health Canada drug master file ...more  
85
Discussion
Comment by QContinuum1on Jul 04, 2024 4:10pm

RE:RE:RE:RE:Germany Booming

I understand that they entered the markets perhaps prematurely and signed those partnerships in advance of real policies needed to engage in those markets.  That is not the case any longer ...more  
59
Discussion
Post by pidukson Jul 04, 2024 3:09pm

Because MPL is a tiny niche player in

the German market and their so called big partner STADA is also a niche player.   That is why you never see a big revenue jump for MPL in Germany.  Read this from 2019 while sleeze ball ...more  
70
Comment by Starkickeron Jul 04, 2024 2:49pm

RE:RE:RE:Germany Booming

Yeah, good question.  There never seems to be a revenue bump with any of these partnerships and new market entries.  Back around 2018 LABS sent out all kinds of press releases about entering ...more  
44
Discussion
Comment by QContinuum1on Jul 04, 2024 2:37pm

RE:RE:Germany Booming

Agreed 100%.  Which is something I have a hard time reconciling.  If the market is booming and we have a Stada in our corner, how is it that sales don't materially increase? The post ...more  
48
Discussion
Comment by Starkickeron Jul 04, 2024 2:29pm

RE:Germany Booming

The German market is nice but it's a false hope on moving the SP up. LABS sold $1.4M in Germany in Q1. Even if that doubles, which it won't in Q2, we're still talking miniscule sales ...more  
41
Discussion
Post by pidukson Jul 04, 2024 2:13pm

Our markets over here in the U.S. are shut

down today and so can see how much 'interest' there is Medipharm Labs when the 'cow milkers' are taking a day off in the U.S., a whopping $2400 dollar volume traded.   I ...more  
57
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities